Related Experiment Video
Updated: Jun 27, 2025
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
13.9K
Depression Treatment in Pregnancy: Is It Safe, or Is It Not?
Vitalba Gallitelli1, Rita Franco1, Sofia Guidi2
1Division of Gynecology and Obstetrics, Isola Tiberina Gemelli Hospital, 00186 Rome, Italy.
Summary
Prenatal depression poses risks to mothers and babies, but safe treatments exist. Specialized medical care ensures the best outcomes for maternal mental health during pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Psychiatry
- Perinatal Mental Health
Background:
- Prenatal depression significantly impacts maternal and fetal well-being.
- Untreated depression during pregnancy is linked to adverse outcomes like miscarriage and neonatal growth issues.
- Concerns regarding antidepressant use necessitate careful consideration during gestation.
Purpose of the Study:
- To review antidepressant medications used during pregnancy.
- To assess the risks and benefits of these treatments.
- To highlight the importance of specialized medical supervision.
Main Methods:
- Literature review of antidepressant drugs and their effects during pregnancy.
- Analysis of risks and benefits associated with various treatments.
- Assessment of teratogenic effects and side effects.
Main Results:
- Specialized medical supervision by multidisciplinary teams is crucial for managing prenatal depression.
- Safe treatment options are available, utilizing drugs with no teratogenic effects and minimal side effects.
- Effective management requires a combination of awareness, early diagnosis, clear guidelines, and treatment.
Conclusions:
- Depression during pregnancy can be treated safely with appropriate medical guidance.
- Choosing antidepressants with favorable safety profiles is essential for mother and child.
- Comprehensive strategies are vital for mitigating the impact of perinatal depression.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
44
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.6K
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
01:25Antidepressant Drugs: Overview
459
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
459
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
377
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
377
01:30Electroconvulsive Therapy
37
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
37
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:18Depression: Overview
242
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
242